Plasma heme-induced renal toxicity is related to a capillary rarefaction

Archive ouverte

Tabibzadeh, Nahid | Estournet, Céline | Placier, Sandrine | Perez, Joëlle | Bilbault, Héloïse | Girshovich, Alexis | Vandermeersch, Sophie | Jouanneau, Chantal | Letavernier, Emmanuel | Hammoudi, Nadjib | Lionnet, François | Haymann, Jean-Philippe

Edité par CCSD ; Nature Publishing Group -

International audience. Severe hypertension can lead to malignant hypertension (MH) with renal thrombotic microangiopathy and hemolysis. The role of plasma heme release in this setting is unknown. We aimed at evaluating the effect of a mild plasma heme increase by hemin administration in angiotensin II (AngII)-mediated hypertensive rats. Prevalence of MH and blood pressure values were similar in AngII and AngII + hemin groups. MH rats displayed a decreased renal blood flow (RBF), increased renal vascular resistances (RVR), and increased aorta and interlobar arteries remodeling with a severe renal microcirculation assessed by peritubular capillaries (PTC) rarefaction. Hemin-treated rats with or without AngII displayed also a decreased RBF and increased RVR explained only by PCT rarefaction. In AngII rats, RBF was similar to controls (with increased RVR). PTC density appeared strongly correlated to tubular damage score (rho = −0.65, p < 0.0001) and also renal Heme Oygenase-1 (HO-1) mRNA (rho = −0.67, p < 0.0001). HO-1 was expressed in PTC and renal tubules in MH rats, but only in PTC in other groups. In conclusion, though increased plasma heme does not play a role in triggering or aggravating MH, heme release appears as a relevant toxic mediator leading to renal impairment, primarily through PTC endothelial dysfunction rather than direct tubular toxicity.

• Description
• Sujet/Public
• Outil
• Outil d'anticipation
• Mémoire et thèse
• Gestion